CLChuanzhen Liu

Chuanzhen Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chuanzhen Liu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling

    by Xin Lv, Jianhua Li, Ruyuan Wei, Lingwei Meng, Xiangjin Kong, Kaiming Wei, Mengmeng Tang, Kai Liu, Chuanzhen Liu

    Pulmonary arterial hypertension (PAH) is a pathophysiological syndrome that is extremely difficult to manage, and there is currently no effective treatment. We want to elucidate the therapeutic effect of ethyl pyruvate (EP) on PAH and its possible mechanism. Pulmonary artery endothelial cells (PAECs) were cultured in conventional low-oxygen environments, and cellular proliferation was monitored after treatment with EP. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 was detected by Western blot. After hyperkinetic PAH rabbits’ models were treated with EP, hemodynamic data were collected. Right ventricular hypertrophy and pulmonary vascular remodeling were evaluated. Expression of p-PI3K/Akt, LC3-II, and Beclin-1 protein was also detected after using autophagy inhibitor and agonists. We found that EP could inhibit PAECs proliferation. After EP treatment, expression of p-PI3K/Akt was upregulated in vitro and in vivo. LC3-II and Beclin-1 were inhibited and their expression was lower after autophagy inhibitor was given, while after administration of autophagy agonists, their expression was higher than that in the EP alone group. Besides, EP attenuated PAH, and right ventricular hypertrophy and pulmonary vascular remodeling were also reversed. EP can reduce PAH and reverse vascular remodeling which is associated with inhibition of autophagy in PAECs based on PI3K-Akt signaling pathway. The results of this study can provide surgical opportunities for patients with severe PAH caused by congenital heart disease in clinical cardiovascular surgery.


  • Open Access

    An unusual anterior mitral leaflet perforation in a patient with no infective endocarditis: a case report

    by Kaiming Wei, Yu Yao, Chuanzhen Liu, Yuan Cao

    Background: Mitral valve perforation refers to the occurrence of cracks or openings in the structure of the mitral valve, allowing blood to escape through these gaps. Typically, this is caused by infective endocarditis and the most common site is the anterior leaflet. However, it is crucial to explore other potential causes of valve damage, particularly when conventional risk factors are not apparent. Case presentation: We present a case of a middle-aged male patient who developed mitral valve perforation because of aortic valve regurgitation in the absence of infective endocarditis. Conclusion: Exploring such rare cases contributes to a deeper understanding of valvular diseases and enhances clinical decision making for effective management.


  • Open Access

    A Mendelian randomization-based study of the causal relationship between cardiovascular-related diseases and endocarditis

    by Jianhua Li, Xin Lv, Lingwei Meng, Chuanzhen Liu

    Objective: To investigate the causal relationship between cardiovascular-related diseases (coronary artery disease, heart failure, diabetes mellitus, systolic and diastolic blood pressure) and endocarditis. Methods: A two-sample Mendelian randomization (MR) study was performed to evaluate the causal effect of cardiovascular-related diseases on endocarditis. Statistical summaries for the associations between single nucleotide polymorphisms (SNPs) and traits of interest were obtained from independent consortia with European populations. The dataset of cardiovascular-related diseases was acquired from genome-wide association studies (GWAS), including cases and controls (coronary artery disease:122733 cases and 424528 controls, hear failure: 47309 cases and 930014 controls, diabetes mellitus: 61714 cases and 1178 controls, systolic and diastolic blood pressure: 757601 samples). A GWAS with 1080 endocarditis cases and 485404 controls was used to identify genetic variation underlying cardiovascular-related diseases. Five complementary MR methods were performed, including inverse variance weighted method (IVW), MR-Egger, weighted median, weighted mode, simple mode. Results: Genetically predicted coronary artery disease (odds ratio [OR] 1.326, 95%CI 1.085-1.622), heart failure (OR 1.961, 95%CI 1.103-3.487), systolic blood pressure (OR 1.039, 95%CI 1.023-1.055) and diastolic blood pressure (OR 1.030, 95%CI 1.002-1.059) was significantly positively associated with endocarditis. Diabetes was not associated with endocarditis (p=0.33). Conclusion: Coronary arterial disease, heart failure and hypertension were high risk factors of endocarditis while diabetes was not.